Cancer is a complex disease at the level of both cells and tissues, and uncovering novel treatments requires understanding the biology and organization of many different cell types and tissues. The ...

Queen Mary University of London has become the first university outside of North America to acquire a Cell DIVE imager, providing access to the latest technology and ensuring that we remain ...

Editor’s note: BioPharma Dive, as part of Emerging Biotech Weekly, is taking a closer look at competitive areas of startup activity. We aim to give an overview of the companies developing a new ...

Immunotherapies, including immune checkpoint inhibitors, have emerged as promising treatments for advanced cancers. However, a subset of patients exhibits resistance to such therapies, and the precise ...